Asymmetric dimethylarginine (ADMA) as a predictor of depression

被引：0
|
作者：
Oglodek, E. [1 ]
Just, M. J. [2 ]
Mos, D. M. [3 ]
Just, K. [4 ]
Fraszczak, M. [1 ]
Araszkiewicz, A. [1 ]
机构：
[1] Nicolaus Copernicus Univ Torun Bydgoszcz Poland, Coll Med Bydgoszcz, Dept Psychiat, Bydgoszcz, Poland
[2] Municipal Hosp Piekary Slaskie Poland, Dept Gen & Endocrine Surg, Piekary Slaskie, Poland
[3] Euromed Bytom Poland, Hlth Care Ctr Bytom Poland, Bytom, Poland
[4] Nicolaus Copernicus Univ Torun Bydgoszcz Poland, Coll Med Bydgoszcz, Dept Psychiat, Bytom, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
ECT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.025
引用
收藏
页码：S468 / U302
页数：2
相关论文
共 50 条
  • [1] Asymmetric dimethylarginine (ADMA) as a predictor of depression
    Oglodek, E.
    Just, M. J.
    Mos, D. M.
    Just, K.
    Fraszczak, M.
    Araszkiewicz, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26
  • [2] IS ASYMMETRIC DIMETHYLARGININE (ADMA) PLASMA LEVEL A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS WITH CIRRHOSIS?
    Sartori, M.
    Andorno, S.
    Rolla, R.
    Pagliarulo, M.
    Garello, E.
    Carmagnola, S.
    Ballare, M.
    Orsello, M.
    Montino, F.
    Suno, A.
    Bellomo, G.
    Del Piano, M.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S102 - S102
  • [3] Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy
    Beltowski, Jerzy
    Kedra, Anna
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 159 - 178
  • [4] The synthesis and metabolism of asymmetric dimethylarginine (ADMA)
    James M. Leiper
    Patrick Vallance
    European Journal of Clinical Pharmacology, 2006, 62 : 33 - 38
  • [5] ASYMMETRIC DIMETHYLARGININE (ADMA) IN ENDOCRINE DISEASES
    Altinova, Alev Eroglu
    Arslan, Metin
    MARMARA MEDICAL JOURNAL, 2009, 22 (01): : 80 - 84
  • [6] The synthesis and metabolism of asymmetric dimethylarginine (ADMA)
    Leiper, JM
    Vallance, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (Suppl 1) : 33 - 38
  • [7] The impact of ADMA (asymmetric dimethylarginine) on diabetes
    Galal, O.
    Verspohl, E. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 36 - 36
  • [8] Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
    Tain, You-Lin
    Hsu, Chien-Ning
    TOXINS, 2017, 9 (03):
  • [9] Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease
    Wolf, Christian
    Lorenzen, Johan M.
    Stein, Sylvia
    Tsikas, Dimitrios
    Stoerk, Stefan
    Weidemann, Frank
    Ertl, Georg
    Anker, Stefan D.
    Bauersachs, Johann
    Thum, Thomas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (03) : 289 - 294
  • [10] Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
    Dimitrios Tsikas
    Alexander Bollenbach
    Erik Hanff
    Arslan Arinc Kayacelebi
    Cardiovascular Diabetology, 17
12345